The Oxford/AstraZeneca COVID-19 vaccine
The Oxford / AstraZeneca COVID-19 vaccine is estimated to have saved more than six million lives – more than any other COVID vaccine, during the first year of use1.
The vaccine itself, the chimpanzee adenovirus vector technology used to produce it, and the manufacturing method which enabled production of over three billion doses were all developed in the Jenner Institute. The clinical trials of the vaccine were performed in partnership with the Oxford Vaccine Group (part of the University’s Department of Paediatrics) and trial sites around the UK and internationally, including Brazil and South Africa.
This website tells the story of the Jenner Institute’s contribution to the vaccine.
1 Airfinity. AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination. 13/7/22 2022. https://www.airfinity.com/insights/astrazeneca-and-pfizer-biontech-saved-over-12-million-lives-in-the-first (accessed 12/8/22).